Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study (Q36461809)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study |
scientific article |
Statements
1 reference
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study (English)
1 reference
Malcolm E Molyneux
1 reference
Steven R Meshnick
1 reference
Ebbie Chaluluka
1 reference
Victor Mwapasa
1 reference
Alejandro L Antonia
1 reference
Gaoqian Feng
1 reference
Steve M Taylor
1 reference
22 March 2012
1 reference
1 reference
42-50
1 reference
Identifiers
1 reference
1 reference
1 reference